KS
Kelly Shi Jefferies Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$30.7B
| $145.10 | $148 |
2%
upside
| Buy |
13 Aug ‘25
26 days ago |
|
2
Cogent Biosciences
COGT
$1.82B
| $13.05 | $28 |
115%
upside
| Buy |
7 Jul ‘25
2 months ago |
|
3
Summit Therapeutics
SMMT
$19.3B
| $25.98 | $44 |
69%
upside
| Buy |
25 Apr ‘25
4 months ago |
|
4
Verastem
VSTM
$663M
| $10.77 | $15 |
39%
upside
| Buy |
10 Apr ‘25
5 months ago |
|
5
Instil Bio
TIL
$213M
| $31.50 | $52 |
65%
upside
| Buy |
7 Jan ‘25
8 months ago |
|
6
Foghorn Therapeutics
FHTX
$326M
| $5.77 | $14 |
143%
upside
| Buy |
16 Dec ‘24
8 months ago |
|
|
CNTA
7
Centessa Pharmaceuticals
CNTA
$2.11B
| $15.73 | $19 |
21%
upside
| Buy |
11 Sep ‘24
1 year ago |
|
8
Ascendis Pharma
ASND
$12.5B
| $205.91 | $196 |
5%
downside
| Buy |
13 Aug ‘24
1 year ago |
|
|
ARTV
9
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$88.2M
| $3.61 | $21 |
482%
upside
| Buy |
13 Aug ‘24
1 year ago |
|
10
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.04 | $37 |
117%
upside
| Buy |
28 Jun ‘24
1 year ago |
|
11
ProKidney
PROK
$304M
| $2.25 | $6 |
167%
upside
| Buy |
10 Jun ‘24
1 year ago |
|
12
PTC Therapeutics
PTCT
$4.55B
| $57.26 | $46 |
20%
downside
| Buy |
20 May ‘24
1 year ago |
|
13
Incyte
INCY
$16.9B
| $86.64 | $81 |
7%
downside
| Buy |
23 Feb ‘24
1 year ago |
|
14
ArriVent BioPharma
AVBP
$819M
| $20.19 | $35 |
73%
upside
| Buy |
20 Feb ‘24
1 year ago |
|
15
Cabaletta Bio
CABA
$155M
| $1.70 | $36 |
2,018%
upside
| Buy |
5 Feb ‘24
1 year ago |
|
|
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $341.80 | $287 |
16%
downside
| Buy |
17 Aug ‘23
2 years ago |
|
17
MoonLake Immunotherapeutics
MLTX
$3.77B
| $59.44 | $16 |
73%
downside
| Buy |
11 Nov ‘22
2 years ago |
|
18
Kymera Therapeutics
KYMR
$3.11B
| $43.51 | $40 |
8%
downside
| Buy |
15 Aug ‘22
3 years ago |
|
19
Monte Rosa Therapeutics
GLUE
$305M
| $4.94 | $20 |
305%
upside
| Buy |
15 Aug ‘22
3 years ago |
|
20
ImmunityBio
IBRX
$2.27B
| $2.40 | $8 |
233%
upside
| Buy |
3 Aug ‘22
3 years ago |
|
21
Adicet Bio
ACET
$60M
| $0.7203 | $27 |
3,648%
upside
| Buy |
4 Mar ‘22
3 years ago |
|
22
HUTCHMED
HCM
$2.74B
| $15.97 | $52 |
226%
upside
| Buy |
3 Aug ‘21
4 years ago |
|
|
CNTB
23
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$97.5M
| $1.75 | $27 |
1,443%
upside
| Buy |
13 Apr ‘21
4 years ago |
|
|
ADAG
24
Adagene
ADAG
$104M
| $2.20 | $33 |
1,400%
upside
| Buy |
8 Mar ‘21
4 years ago |
|